Cagrilintide 5mg + Semaglutide 5mg Research Grade Peptide Powder

This product is a research-grade composite peptide powder containing Cagrilintide 5mg and Semaglutide 5mg per unit. It is manufactured in strict accordance with ECHEMI pharmaceutical polypeptide standards, with purity ≥98% and stable quality. Designed exclusively for laboratory research, scientific experiments, and raw material development, it is not for human therapeutic use or clinical administration.

• 

  1. Reconstitution

     
     

     Conduct all operations in a sterile laboratory environment. Add an appropriate amount of sterile water or bacteriostatic water to dissolve the lyophilized powder. Gently swirl the vial, do not shake vigorously to prevent peptide denaturation.
     
     
  2. Solution Preparation

     
     

     Prepare working solutions in accordance with your experimental protocols. Use sterile lab utensils to avoid contamination.
     
     
  3. Solution Management

     
     

     The prepared solution can be stored at 2–8°C for short-term use within 30 days. For long-term storage, aliquot the solution and store at -20°C. Repeated freeze-thaw cycles are not allowed.
     
     

  
  

  ⚠️ Disclaimer

  
  

  This product is solely for laboratory research. It is prohibited for human, animal and clinical applications. Users shall take full responsibility for any improper use.
• 
  
• 
  
• 
  

• 1. Unopened lyophilized powder

     
     

     Keep sealed vials at -20°C, store in dry and dark place. Keep away from direct sunlight, moisture and frequent temperature changes. Shelf life: 24 months under standard storage conditions.
     
     
  2. Reconstituted solution

     
     

     For short-term use, store at 2–8°C and use up within 30 days. For long-term storage, aliquot and freeze at -20°C. Avoid repeated freeze-thaw cycles.
     
     

  
  

  ⚠️ Disclaimer

  
  

  This product is for laboratory research only. Improper storage will affect reagent stability. All consequences caused by misuse shall be borne by the user.

Core Business & Product Portfolio

• Therapeutic peptides: SS-31 (Elamipretide), Tirzepatide, Semaglutide, Retatrutide (RT20), etc.
• Functional peptides: GHK-Cu, TB500, KPV, NAD, Glutathione, etc.
• Custom peptide services: Custom synthesis of complex sequences, long-chain peptides (up to 200 amino acids) and cyclic peptides, as well as various modification services (N-methylation, unusual amino acid incorporation, etc.).

R&D & Manufacturing Strength

• Technical expertise: Mastery of core technologies including solid-phase peptide synthesis (SPPS), liquid-phase synthesis, advanced purification (HPLC) and strict structural characterization.
• Quality assurance: All products are produced in compliance with cGMP standards, with complete CoA, HPLC and MS reports to ensure batch-to-batch consistency and high purity (≥98%).
• Production capacity: Equipped with professional production bases in Guangzhou, supporting small-batch R&D samples to large-scale commercial production, with stable supply capacity.

Global Market & Service Philosophy

Vision